BFRI Stock Discussion

Biofrontera Inc. Description

Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Antineoplastic Drugs Melanoma Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer